Skip To Content

ACD/Labs Blog

President and CEO, Daria Thorp, reflects on the past year and how the emerging technology of Generative AI and Machine Learning (ML) application in drug discovery and development has inspired companies to look for further industrial applications.

A new year is historically a time for reflection. In 2022, ACD/Labs has been in the scientific software industry for 28 years. In this blog post, Andrew Anderson reflects on three key topics have come up repeatedly in conversations with customers in 2022 that are notable for our work ahead.

Andrew Anderson recently shared his insight on workflow automation trends in a Pharma Manufacturing article. He emphasizes taking a quality-first approach throughout the automation, digitalization, and analysis processes to truly realize the benefits of Industry 4.0. Here are some of the highlights.